Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD 2022-05-26 20:44
GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects 2022-05-26 14:25
Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts 2022-05-25 23:04
The Centre for Probe Development and Commercialization expands into Asia and executes a development, manufacturing, and clinical supply agreement for 177Lu-PSMA (DGUL) With South Korea-based CellBion 2022-05-25 21:00
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic 2022-05-25 19:00
CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions 2022-05-25 07:00
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment 2022-05-25 05:00
ICP DAS - BMP will attend Medical Taiwan Expo 2022 in Taipei 2022-05-25 01:25
Eurofins Discovery Announces Formation of its New Scientific Advisory Board 2022-05-24 23:00
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment 2022-05-24 21:00
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention 2022-05-24 20:00
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis 2022-05-24 19:00
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand 2022-05-23 20:28
Antengene Announces First Patient Dosed in the Phase I/II SWATCH Study of XPOVIO® (Selinexor) for the Treatment of B-Cell Non-Hodgkin Lymphomas 2022-05-23 10:10
Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma 2022-05-21 01:19
Lipidor updates on Phase III study of AKP02 in treatment of psoriasis - half of patients now recruited 2022-05-20 14:56
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays 2022-05-19 20:30
4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022 2022-05-19 20:06
Berry Oncology Launches an Innovative Self-Iterative "HIFI" System 2022-05-19 09:00
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding 2022-05-19 04:56
1 74 75 76 77 78 211